Vigneau, Cécile <br/><br/>
Intermediate-dose (25mg/m2) IV melphalan for multiple myeloma with renal failure.  [electronic resource] 

 -  Journal of nephrology   
 - 684-9 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1121-8428 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Cohort Studies<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Maximum Tolerated Dose<br/>Melphalan--administration & dosage<br/>Middle Aged<br/>Multiple Myeloma--complications<br/>Pilot Projects<br/>Probability<br/>Prognosis<br/>Prospective Studies<br/>Renal Insufficiency--complications<br/>Risk Assessment<br/>Severity of Illness Index<br/>Survival Analysis<br/>Treatment Outcome